461 related articles for article (PubMed ID: 32095835)
1. Mental Health Costs of Inflammatory Bowel Diseases.
Szigethy E; Murphy SM; Ehrlich OG; Engel-Nitz NM; Heller CA; Henrichsen K; Lawton R; Meadows P; Allen JI
Inflamm Bowel Dis; 2021 Jan; 27(1):40-48. PubMed ID: 32095835
[TBL] [Abstract][Full Text] [Related]
2. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data.
Long GH; Tatro AR; Oh YS; Reddy SR; Ananthakrishnan AN
Adv Ther; 2019 Nov; 36(11):3079-3095. PubMed ID: 31562607
[TBL] [Abstract][Full Text] [Related]
4. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.
Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y
J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540
[TBL] [Abstract][Full Text] [Related]
5. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
Tan MC; El-Serag HB; Hou JK
Dig Dis Sci; 2017 Mar; 62(3):607-614. PubMed ID: 28012103
[TBL] [Abstract][Full Text] [Related]
6. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
[TBL] [Abstract][Full Text] [Related]
7. A Phenome-Wide Analysis of Healthcare Costs Associated with Inflammatory Bowel Diseases.
Cai W; Cagan A; He Z; Ananthakrishnan AN
Dig Dis Sci; 2021 Mar; 66(3):760-767. PubMed ID: 32436120
[TBL] [Abstract][Full Text] [Related]
8. Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study.
Lee J; Im JP; Han K; Kim J; Lee HJ; Chun J; Kim JS
Gut Liver; 2020 Jan; 14(1):89-99. PubMed ID: 31158951
[No Abstract] [Full Text] [Related]
9. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
[TBL] [Abstract][Full Text] [Related]
10. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
Click B; Lopez R; Arrigain S; Schold J; Regueiro M; Rizk M
Inflamm Bowel Dis; 2020 Jul; 26(8):1268-1275. PubMed ID: 31671186
[TBL] [Abstract][Full Text] [Related]
11. National Trends in Emergency Department Visits by Adults With Mental Health Disorders.
Capp R; Hardy R; Lindrooth R; Wiler J
J Emerg Med; 2016 Aug; 51(2):131-135.e1. PubMed ID: 27614303
[TBL] [Abstract][Full Text] [Related]
12. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.
Kappelman MD; Rifas-Shiman SL; Porter CQ; Ollendorf DA; Sandler RS; Galanko JA; Finkelstein JA
Gastroenterology; 2008 Dec; 135(6):1907-13. PubMed ID: 18854185
[TBL] [Abstract][Full Text] [Related]
13. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
[TBL] [Abstract][Full Text] [Related]
14. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
15. The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
Rubin DT; Feld LD; Goeppinger SR; Margolese J; Rosh J; Rubin M; Kim S; Rodriquez DM; Wingate L
Inflamm Bowel Dis; 2017 Feb; 23(2):224-232. PubMed ID: 27997434
[TBL] [Abstract][Full Text] [Related]
16. Self-reported Health Care Utilization of Patients with Inflammatory Bowel Disease Correlates Perfectly with Medical Records.
Severs M; Petersen RE; Siersema PD; Mangen MJ; Oldenburg B
Inflamm Bowel Dis; 2016 Mar; 22(3):688-93. PubMed ID: 26835981
[TBL] [Abstract][Full Text] [Related]
17. Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes.
Nene S; Gonczi L; Kurti Z; Morin I; Chavez K; Verdon C; Reinglas J; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
World J Gastroenterol; 2020 Feb; 26(7):759-769. PubMed ID: 32116423
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
19. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
[TBL] [Abstract][Full Text] [Related]
20. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
